UroGen Pharma URGN
NASDAQ URGN
$25.32 -0.99 (-3.76%)
As of: Nov 10, 2026 · 3:59 PM EST

UroGen Pharma (URGN) Raw Materials (2020 - 2021)

Updated

UroGen Pharma (URGN) reported Raw Materials of $2.44 million for Q1 2021, up 132.4% from the prior quarter.

Analysis

UroGen Pharma (URGN) Raw Materials (2020 - 2021) Analysis & Trends

At the end of FY2020, UroGen Pharma posted Raw Materials of $1.05 million.

  • Per Business Quant data, the three quarters before Q1 2021 came in at $1.05 million (Q4 2020), $927,000 (Q3 2020) and $893,000 (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 UroGen Pharma 1.31 Bn 855.26 Mn 81.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 2.44 Mn
Dec 31, 2020 1.05 Mn
Sep 30, 2020 927,000.00
Jun 30, 2020 893,000.00
API Access

UroGen Pharma Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=URGN&period=max&api_key=YOUR_API_KEY